Verastem | VSTM - Ebit

Verastem reported $-16846000 in EBIT for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebit Change
AstraZeneca AZN:LN USD 1.84B 429M
Curis CRIS:US USD -10220000 2.39M
Cytokinetics CYTK:US USD -127030000 18.59M
Gilead Sciences GILD:US USD 2.27B 565M
Immunogen IMGN:US USD -59559000 17.87M
Laboratory Of America LH:US USD 720.2M 235.7M
Novartis NOVN:VX USD 3.1B 228M
Pfizer PFE:US USD 5.81B 3.89B
Roche Holding ROG:VX 8.49B 3.05B
Tg Therapeutics TGTX:US USD -52062000 17.1M
Verastem VSTM:US USD -16846000 863K
YTE INCY:US USD 93.36M 24.89M
Ziopharm Oncology ZIOP:US USD -8521000 257K